CEEMAST DRY COW INTRAMAMMARY SUSPENSION

Country: Ireland

Language: English

Source: HPRA (Health Products Regulatory Authority)

Active ingredient:

CEFALEXIN, DIHYDROSTREPTOMYCIN (AS DIHYDROSTREPTOMYCIN SUPLHATE) PH. EUR.

Available from:

Cross Vetpharm Group Limited

ATC code:

QJ51RD01

INN (International Name):

CEFALEXIN, DIHYDROSTREPTOMYCIN (AS DIHYDROSTREPTOMYCIN SUPLHATE) PH. EUR.

Dosage:

500/500 mg/syringe

Pharmaceutical form:

intramammary Suspension

Prescription type:

POM

Therapeutic group:

Bovine

Therapeutic area:

Cefalexin, combinations with other antibacterials

Therapeutic indications:

Antibacterial

Authorization status:

Authorised

Authorization date:

2008-02-15

Summary of Product characteristics

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
CEEMAST Dry Cow Intramammary Suspension
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
3 PHARMACEUTICAL FORM
Intramammary suspension.
10 ml intramammary syringe containing 9 g of a smooth pale pink or pale yellow sterile product.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Dry cows.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the treatment of sub clinical mastitis infection present at drying off in cows and to assist in preventing new
infections occurring during the dry period.
4.3 CONTRAINDICATIONS
Do not use in animals with known hypersensitivity to the active ingredients.
Do not use in lactating cows.
Do not use within 40 days of the estimated calving date.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
Each syringe contains:
Active Substances
Cefalexin
500 mg
Dihydrostreptomycin
(as Dihydrostreptomycin Sulphate)
500 mg
For a full list of excipients see section 6.1
HEALTH PRODUCTS REGULATORY AUTHORITY
________________________________________________________________________________________________________________________
_Date Printed 04/08/2016_
_CRN 7024410_
_page number: 1_
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Not intended for use within 40 days of the estimated calving date.
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE VETERINARY MEDICINAL PRODUCT TO ANIMALS
Operators should avoid contact with this preparation as occasional skin allergy may
occur.
Penicillins and cephalosporins may cause hypersensitivity following injection, inhalation, ingestion or skin contact.
Hypersensitivity to penicillins may lead to cross reactions to cephalosporins and vice versa. Allergic reactions to these
substances may occasionally be serious.
Do not handle this product if you know that